Bendamustine in combination with high-dose radiotherapy and thalidomide is effective in treatment of multiple myeloma with central nervous system involvement

被引：21
|
作者：
Nahi, Hareth [1 ]
Svedmyr, Erik [1 ]
Lerner, Richard [1 ]
机构：
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2014年 / 92卷 / 05期
关键词：
THERAPY; AGENTS;
D O I：
10.1111/ejh.12247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：454 / 455
页数：2
相关论文
共 46 条
  • [1] The combination topotecan, temozolomide and dexamethasone associated with radiotherapy as treatment of central nervous system myeloma relapse
    Annibali, Ombretta
    Nobile, Carolina
    Greco, Rosa
    Cellini, Francesco
    Quattrocchi, Carlo Cosimo
    Tirindelli, Maria Cristina
    Petrucci, Maria Teresa
    Avvisati, Giuseppe
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (04) : 513 - 516
  • [2] High-dose methotrexate, high-dose cytarabine and temozolomide for the treatment of primary central nervous system lymphoma (PCNSL)
    Salamoon, Maher
    Hussein, Taisir
    Kenj, Mazen
    Bachour, Marrouan
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [3] The role of high-dose chemotherapy in the treatment of multiple myeloma: A controversy
    Kyle, RA
    ANNALS OF ONCOLOGY, 2000, 11 : 55 - 58
  • [4] Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment
    Vaxman, Iuliana
    Al Saleh, Abdullah S.
    Kumar, Shaji
    Nitin, Mishra
    Dispenzieri, Angela
    Buadi, Francis
    Dingli, David
    Lacy, Martha
    Muchtar, Eli
    Hobbs, Miriam
    Fonder, Amie
    Hwa, Lisa
    Visram, Alissa
    Kapoor, Prashant
    Siddiqui, Mustaqeem
    Lust, John
    Kyle, Robert
    Rajkumar, Vincent
    Hayman, Suzanne
    Leung, Nelson
    Gonsalves, Wilson
    Kourelis, Taxiarchis
    Warsame, Rahma
    Gertz, Morie A.
    CANCER MEDICINE, 2020, 9 (23): : 8895 - 8901
  • [5] A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma
    Lokhorst, Henk M.
    van der Holt, Bronno
    Zweegman, Sonja
    Vellenga, Edo
    Croockewit, Sandra
    van Oers, Marinus H.
    Borne, Peter von dem
    Wijermans, Pierre
    Schaafsma, Ron
    de Weerdt, Okke
    Wittebol, Shulamiet
    Delforge, Michel
    Berenschot, Henriette
    Bos, Gerard M.
    Jie, Kon-Siong G.
    Sinnige, Harm
    van Marwijk-Kooy, Marinus
    Joosten, Peter
    Minnema, Monique C.
    van Ammerlaan, Rianne
    Sonneveld, Pieter
    BLOOD, 2010, 115 (06) : 1113 - 1120
  • [6] Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experience
    Lue, Shuqing
    Wang, Jianmin
    Xu, Xiaoqian
    Ni, Xiong
    Huang, Chongmei
    Qiu, Huiying
    Hu, Xiaoxia
    Yang, Jianmin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (01) : 34 - 38
  • [7] High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma
    Samur, Mehmet Kemal
    Roncador, Marco
    Samur, Anil Aktas
    Fulciniti, Mariateresa
    Bazarbachi, Abdul Hamid
    Szalat, Raphael
    Shammas, Masood A.
    Sperling, Adam S.
    Richardson, Paul G.
    Magrangeas, Florence
    Minvielle, Stephane
    Perrot, Aurore
    Corre, Jill
    Moreau, Philippe
    Thakurta, Anjan
    Parmigiani, Giovanni
    Anderson, Kenneth C.
    Avet-Loiseau, Herve
    Munshi, Nikhil C.
    BLOOD, 2023, 141 (14) : 1724 - 1736
  • [8] Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma
    Hirono, Seiichiro
    Iwadate, Yasuo
    Higuchi, Yoshinori
    Serizawa, Toru
    Nagano, Osamu
    Matsutani, Tomoro
    Saeki, Naokatsu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (02) : 237 - 244
  • [9] High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma
    Gerard, Lauren M.
    Imrie, Kevin R.
    Mangel, Joy
    Buckstein, Rena
    Doherty, Mary
    Mackenzie, Robert
    Cheung, Matthew C.
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1882 - 1890
  • [10] Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System Lymphoma
    Yin, Anyue
    de Groot, Fleur A.
    Guchelaar, Henk-Jan
    Nijland, Marcel
    Doorduijn, Jeanette K.
    Touw, Daan J.
    Munnink, Thijs Oude
    de Winter, Brenda C. M.
    Friberg, Lena E.
    Vermaat, Joost S. P.
    Moes, Dirk Jan A. R.
    CLINICAL PHARMACOKINETICS, 2025, 64 (01) : 79 - 91
12345